Funded Grants

PI Name Organization Title Project Number Fiscal Yearsort descending Major Program/Research Group
Wu, Yun State University Of New York At Buffalo Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis 5R33CA191245-03 2017 Cancer Biomarkers
Roy, Hemant K. Boston Medical Center Area B: Minimally Intrusive Colorectal Cancer Risk Stratification with Nanocytology: Targeting Underscreened Populations 1R33CA225323-01 2017 Early Detection
Lee, Ly James Ohio State University Molecular Beacon Based Extracellular mRNA and Protein Detection for Early Cancer Diagnosis 1R33CA225380-01 2017 Early Detection
STEIN, JANET L UNIVERSITY OF VERMONT & ST AGRIC COLLEGE Vermont Breast Cancer Molecular Characterization Laboratory 3U01CA196383-03S1 2017 Molecular and Cellular Characterization
BROOKS, JAMES D. STANFORD UNIVERSITY Stanford Molecular and Cellular Characterization Laboratory 3U01CA196387-03S1 2017 Molecular and Cellular Characterization
PIENTA, KENNETH J. JOHNS HOPKINS UNIVERSITY Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry 3U01CA196390-03S1 2017 Molecular and Cellular Characterization
MAITRA, ANIRBAN UNIVERSITY OF TX MD ANDERSON CAN CTR Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas 3U01CA196403-03S1 2017 Molecular and Cellular Characterization
MASSION, PIERRE P. VANDERBILT UNIVERSITY MEDICAL CENTER Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma 3U01CA196405-04S1 2017 Molecular and Cellular Characterization
WANG, TIMOTHY CRAGIN COLUMBIA UNIVERSITY HEALTH SCIENCES The Role of the Microenvironment in Barrett's Esophagus 2U54CA163004-06 2017 Gastrointestinal and Other Cancers, Barrett's Esophagus Translational Research Network
Beretta, Laura UNIVERSITY OF TX MD ANDERSON CAN CTR Prevention of Hepatocellular Carcinoma (HCC) Associated with Non Alcoholic Steatohepatitis (NASH) 261201500018I-0-26100007-1 2018 PREVENT Cancer Preclinical Drug Development Program
Brown, Powel UNIVERSITY OF TX MD ANDERSON CAN CTR Targeting the RXR Pathway for the Prevention of Triple Negative Breast Cancer 261201500018I-0-26100008-1 2018 PREVENT Cancer Preclinical Drug Development Program
Brown, Powel UNIVERSITY OF TX MD ANDERSON CAN CTR RANK Ligand Inhibition: A Potential Chemoprevention Strategy for Women at High Genetic Risk of Breast Cancer 261201500018I-0-26100009-1 2018 PREVENT Cancer Preclinical Drug Development Program
McCormick, David IIT RESEARCH INSTITUTE LFA-9 (mPGES-1/5-LOX Inhibitor): Preclinical Investigational New Drug (IND)-directed GLP Toxicology Studies 261201500024I-0-26100005-1 2018 PREVENT Cancer Preclinical Drug Development Program
Lyubimov, Alexander UNIVERSITY OF ILLINOIS AT CHICAGO A Dual AKT/PDPK1 Inhibitor for Actinic Keratosis and Skin Cancer Prevention 261201500026I-0-26100003-1 2018 PREVENT Cancer Preclinical Drug Development Program
Grubbs, Clinton UNIVERSITY OF ALABAMA AT BIRMINGHAM Evaluation of STAT3 Antagonists in the Prevention of Mammary Cancer 261201500036I-0-26100007-1 2018 PREVENT Cancer Preclinical Drug Development Program

Pages